Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

RespireRx Pharmaceuticals Inc.

www.respirerx.com

Latest From RespireRx Pharmaceuticals Inc.

Tech Transfer Roundup: Universities And Biotechs Continue To Look For Ways To Combat COVID-19

AlloVir/Baylor, Soligenix/Hawaii and CEL-SCI/Georgia ink coronavirus collaborations, but deal-making continues in other areas as well, including Asklepios/UNC teaming on a gene therapy for Angelman syndrome and DeMelle licensing a targeted pancreatic cancer drug from Moffitt, among others.

Deals Coronavirus COVID-19

Waking Up Market To US Obstructive Sleep Apnea Epidemic

RespireRx president & CEO James Manuso explained to Scrip during the 2018 Biotech Showcase how the company is repurposing an existing drug to tackle the problem of sleep apnea.

Clinical Trials Companies

Phase III Data Boost Prospects For Jazz's Sleep Apnea Drug

Data from two studies in obstructive sleep apnea suggest drug may hold its own against approved generics, analysts say.

Clinical Trials Research & Development

Pipeline Watch: Phase III Starts For CCX168, ETC-1002 And COR-003

Pipeline Watch has been updated to bring greater depth and detail to a potential therapeutic product’s progress through the R&D pipeline. The table brings you a snapshot of selected late-stage clinical trial events in the pharma and biotech industries.

Research & Development Pipeline Watch
See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
  • Therapeutic Areas
  • Neurology, Nervous System
  • Respiratory, Pulmonary
  • Alias(es)
  • Cortex Pharmaceuticals Inc.
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • RespireRx Pharmaceuticals Inc.
  • Senior Management
  • James S Manuso, Pres. & CEO
    Robert N Weingarten, VP, CFO
    Arnold S Lippa, PhD, CSO
    Richard Purcell, SVP, R&D
  • Contact Info
  • RespireRx Pharmaceuticals Inc.
    Phone: (917) 834-7206
    126 Valley Rd., St .
    Glen Rock, NJ 07452
    USA
UsernamePublicRestriction

Register